[English] 日本語
Yorodumi
- BIRD-PRD_000195: Cinnamycin -

+
Open data


ID or keywords:

Loading...

-
Basic information

EntryDatabase: Biologically Interesting Molecule Reference Dictionary (BIRD) / ID: PRD_000195
StatusStatus: REF ONLY
NameCinnamycin

-
BIRD information

TypePolypeptide / Lantibiotic
Details
  • CINNAMYCIN IS A GLOBULAR TYPE B LANTIBIOTIC. THE LANTIBIOTICS ARE CHARACTERIZED BY THIOESTER AMINO ACIDS LANTHIONINE AND/OR METHYLLANTHIONINE. HERE, CINNAMYCIN IS REPRESENTED BY THE SEQUENCE (SEQRES)
  • CINNAMYCIN IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE 14-19 BETA-METHYLLANTHIONINE THIOETHER BOND IS OXIDIZED TO A SULFOXIDE. THE THIOETHER BONDS WITH CYSTEINE RESULT IN THREE RING STRUCTURES, CROSSLINK BETWEEN SER AND LYS RESULT IN THE FOURTH RING. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
DownloadsMolecular definition / Chemical definition / Family definition
Synonyms
  • CINNAMYCIN (PDB)
  • Cinnamycin, hydrochloride (9CI) (SciFinder)
  • Lanthiopeptin (SciFinder, UniProt, PubChem)
  • Lantibiotic Ro 09-0198 (UniProt)
  • NSC 71936 (PubChem)
  • Ro 09-0198 (SciFinder, PubChem)
Annotation
  • Function: Antiviral / Info source: NovelAntibiotics
  • Function: enzyme inhibitor of phospholipase A2 and of angiotensin-converting enzyme / Info source: Bactibase
  • Function: exhibits immunopotentiating and inhibitory activity against herpes simplex virus / Info source: Bactibase
  • Function: inhibitor of the enzymes phospholipase A2, and angiotensin-converting enzyme / Info source: UniProt
  • Function: Shows inhibitory activities against herpes simplex virus and immunopotentiating activities / Info source: UniProt
Source
External info
FamilyLantibiotic

ACTAGARDINE / Cinnamycin / EPILANCIN 15X ...ACTAGARDINE / Cinnamycin / EPILANCIN 15X / BIRD: PRD_000197 / BETA LICHENICIDIN PREPEPTIDE / Mersacidin / Nisin A

Related structures
  • cysteinyl-(alpha-aminobutyryl)-phenylalanyl-(alpha-aminobutyryl)-leucyl-prolyl-glycyl-glycyl-glycyl-glycyl-valyl-cysteinyl-(alpha-aminobutyryl)-leucyl-(alpha-aminobutyryl)-(dehydroalanyl)-glutamyl-cysteinyl-isoleucine 2-sulfanylethenylamide methanol solvate hydrate, Mersacidin methanol solvate hydrate, seqres C9 CYS*!,GLY!-LEU-PRO-GLY-GLY-GLY-GLY-VAL-, C6 ALA!,CYS*!-LEU-CYS*-ALA*-GLU-, C2 CYS*-GLY!, A3 GLY!-PHE-GLY!, A2 ALA!-ILE, A2 CYS*!-CYS*! / CCDC: WOPCAF / Reference

-
Chemical information

Composition
Formula: C89H127N25O25S3 / Formula weight: 2043.308
OthersType: peptide-like
History
External linksUniChem / ChemSpider / Wikipedia search / Google search

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

-
Details

-
SMILES

CACTVS 3.370CC(C)[CH]1NC(=O)[CH](Cc2ccccc2)NC(=O)[CH]3NC(=O)[CH](Cc4ccccc4)NC(=O)[CH]5CCCN5C(=O)CNC(=O)[CH](Cc6ccccc6)NC(=O)[CH]7C[NH2+]CCCC[CH](NC(=O)[CH]8NC(=O)[CH](CC(N)=O)NC(=O)CNC(=O)[CH](NC(=O)[CH](CSC[CH](NC(=O)[CH](CCC(N)=O)NC(=O)[CH](CCCNC(N)=[NH2+])NC(=O)[CH](N)CS[CH]8C)C(=O)N[CH](CS[CH]3C)C(=O)N7)NC1=O)[CH](O)C(O)=O)C(O)=O
OpenEye OEToolkits 1.7.6CC1C2C(=O)NC(C(=O)NC(C(=O)NC3CSCC4C(=O)NC(CS1)C(=O)NC(C[NH2+]CCCCC(NC(=O)C(C(SCC(C(=O)NC(C(=O)NC(C(=O)N4)CCC(=O)N)CCCNC(=[NH2+])N)N)C)NC(=O)C(NC(=O)CNC(=O)C(NC3=O)C(C(=O)O)O)CC(=O)N)C(=O)O)C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)NC(C(=O)N2)Cc6ccccc6)Cc7ccccc7)C(C)C)Cc8ccccc8

-
SMILES CANONICAL

CACTVS 3.370CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H]5CCCN5C(=O)CNC(=O)[C@H](Cc6ccccc6)NC(=O)[C@@H]7C[NH2+]CCCC[C@H](NC(=O)[C@@H]8NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H](N)CS[C@H]8C)C(=O)N[C@@H](CS[C@H]3C)C(=O)N7)NC1=O)[C@@H](O)C(O)=O)C(O)=O
OpenEye OEToolkits 1.7.6CC1[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]3CSC[C@@H]4C(=O)N[C@@H](CS1)C(=O)N[C@@H](C[NH2+]CCCC[C@H](NC(=O)[C@@H](C(SC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4)CCC(=O)N)CCCNC(=[NH2+])N)N)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC3=O)[C@H](C(=O)O)O)CC(=O)N)C(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N[C@H](C(=O)N2)Cc6ccccc6)Cc7ccccc7)C(C)C)Cc8ccccc8

-
InChI

InChI 1.03InChI=1S/C89H125N25O25S3/c1-43(2)66-84(133)109-59-41-140-40-58-79(128)108-60-42-142-45(4)68(86(135)105-55(75(124)110-66)34-48-22-12-7-13-23-48)111-76(125)54(33-47-20-10-6-11-21-47)104-82(131)61-26-17-31-114(61)65(118)38-98-72(121)53(32-46-18-8-5-9-19-46)103-78(127)57(106-80(60)129)36-95-29-15-14-24-52(87(136)137)102-85(134)67(112-77(126)56(35-63(92)116)99-64(117)37-97-83(132)69(113-81(59)130)70(119)88(138)139)44(3)141-39-49(90)71(120)100-50(25-16-30-96-89(93)94)73(122)101-51(74(123)107-58)27-28-62(91)115/h5-13,18-23,43-45,49-61,66-70,95,119H,14-17,24-42,90H2,1-4H3,(H2,91,115)(H2,92,116)(H,97,132)(H,98,121)(H,99,117)(H,100,120)(H,101,122)(H,102,134)(H,103,127)(H,104,131)(H,105,135)(H,106,129)(H,107,123)(H,108,128)(H,109,133)(H,110,124)(H,111,125)(H,112,126)(H,113,130)(H,136,137)(H,138,139)(H4,93,94,96)/p+2/t44-,45-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58+,59-,60-,61-,66-,67+,68+,69-,70+/m0/s1

-
InChIKey

InChI 1.03QJDWKBINWOWJNZ-OURZNGJWSA-P

-
PDB entries

Showing all 1 items

PDB-2dde:
Structure of cinnamycin complexed with lysophosphatidylethanolamine

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more